Glucose for the heart: Too much of a good thing?

Journal of the American College of Cardiology

Volumn 46, Issue 1, 2005, Pages 49-50

  Taegtmeyer, Heinrich ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOSE; OXYGEN;

CARDIOVASCULAR DISEASE; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; EXERCISE TEST; GLUCOSE BLOOD LEVEL; HEART MUSCLE BLOOD FLOW; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; METABOLIC DISORDER; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION;

EID: 21344453064     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.04.014     Document Type: Editorial

References (26)

1. W. Kannel, D. McGee Diabetes and cardiovascular disease the Framingham Study JAMA 241 1979 2035 2038
2. J. Stamler, O. Vaccaro, J. Neaton, D. Wentworth Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial Diabetes Care 16 1993 434 444
3. H. Taegtmeyer, P. McNulty, M.E. Young Adaptation and maladaptation of the heart in diabetes: part I: general concepts Circulation 105 2002 1727 1733
4. S.M. Haffner The importance of hyperglycemia in the nonfasting state to the development of cardiovascular disease Endocr Rev 19 1998 583 592
5. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) Lancet 352 1998 837 853
6. V. Schachinger, M.B. Britten, A.M. Zeiher Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease Circulation 101 2000 1899 1906
7. P.H. McNulty, S. Pfau, L.I. Deckelbaum Effect of plasma insulin level on myocardial blood flow and its mechanism of action Am J Cardiol 85 2000 161 165
8. U. Scherrer, D. Randin, P. Vollenweider, L. Vollenweider, P. Nicod Nitric oxide release accounts for insulin's vascular effects in humans J Clin Invest 94 1994 2511 2515
9. H.O. Steinberg, G. Brechtel, A. Johnson, N. Fineberg, A.D. Baron Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release J Clin Invest 94 1994 1172 1179
10. H. Taegtmeyer, L. Golfman, S. Sharma, P. Razeghi, M. Van Arsdall Linking gene expression to function metabolic flexibility in normal and diseased heart Ann N Y Acad Sci 1015 2004 202 213
11. E. Picano Diabetic cardiomyopathy the importance of being earliest J Am Coll Cardiol 42 2003 454 457
12. H. Taegtmeyer, P. Razeghi Heart disease in diabetes - resist the beginnings (letter) J Am Coll Cardiol 43 2004 315
13. M.F. Di Carli, J. Janisse, G. Grunberger, J. Ager Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes J Am Coll Cardiol 41 2003 1387 1393
14. M.J. Quinones, M. Hernandez-Pampaloni, H. Schelbert Coronary vasomotor abnormalities in insulin-resistant individuals Ann Intern Med 140 2004 700 708
15. M. Srinivasan, P. Herrero, J.B. McGill The effect of plasma insulin and glucose on myocardial blood flow in patients with type 1 diabetes mellitus J Am Coll Cardiol 46 2005 42 48
16. S.B. Williams, J.A. Cusco, M.A. Roddy, M.T. Johnstone, M.A. Creager Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus J Am Coll Cardiol 27 1996 567 574
17. X.L. Du, D. Edelstein, S. Dimmeler, Q. Ju, C. Sui, M. Brownlee Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site J Clin Invest 108 2001 1341 1348
18. H. Taegtmeyer Glycogen in the heart - an expanded view J Mol Cell Cardiol 37 2004 7 10
19. M. Brownlee Biochemistry and molecular cell biology of diabetic complications Nature 414 2001 813 820
20. G. Van den Berghe, P. Wouters, F. Weekers Intensive insulin therapy in critically ill patients N Engl J Med 345 2001 1359 1367
21. G.W. Goodwin, C.S. Taylor, H. Taegtmeyer Regulation of energy metabolism of the heart during acute increase in heart work J Biol Chem 273 1998 29530 29539
22. C. Korvald, O.P. Elvenes, T. Myrmel Myocardial substrate metabolism influences left ventricular energetics in vivo Am J Physiol Heart Circ Physiol 278 2000 H1345 H1351
23. K. Malmberg, L. Ryden, S. Efendic Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study) effects on mortality at 1 year J Am Coll Cardiol 26 1995 57 65
24. H. Taegtmeyer, G.W. Goodwin, T. Doenst, O.H. Frazier Substrate metabolism as a determinant for postischemic functional recovery of the heart Am J Cardiol 80 1997 3A 10A
25. I.C. van der Horst, F. Zijlstra, A.W. van't Hof Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial J Am Coll Cardiol 42 2003 784 791
26. M.E. Young, P. McNulty, H. Taegtmeyer Adaptation and maladaptation of the heart in diabetes: part II: potential mechanisms Circulation 105 2002 1861 1870